Suppr超能文献

滤泡型甲状腺肿瘤的原型差异。

Proteotypic Differences of Follicular-Patterned Thyroid Neoplasms.

机构信息

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.

出版信息

Front Endocrinol (Lausanne). 2022 Jul 6;13:854611. doi: 10.3389/fendo.2022.854611. eCollection 2022.

Abstract

The diagnosis of follicular-patterned thyroid tumors such as follicular thyroid adenoma (FA), follicular thyroid carcinoma (FTC), and follicular variant of papillary thyroid carcinoma (FvPTC) remains challenging. This study aimed to explore the molecular differences among these three thyroid tumors by proteomic analysis. A pressure cycling technology (PCT)-data-independent acquisition (DIA) mass spectrometry workflow was employed to investigate protein alterations in 52 formalin-fixed paraffin-embedded (FFPE) specimens: 18 FA, 15 FTC, and 19 FvPTC specimens. Immunohistochemical (IHC) analysis of 101 FA, 67 FTC, and 65 FvPTC specimens and parallel reaction monitoring (PRM) analysis of 20 FA, 20 FTC, and 20 FvPTC specimens were performed to validate protein biomarkers. A total of 4107 proteins were quantified from 52 specimens. Pairwise comparisons identified 287 differentially regulated proteins between FTC and FA, and 303 between FvPTC and FA and 88 proteins were co-dysregulated in the two comparisons. However, only 23 discriminatory proteins between FTC and FvPTC were detected. Additionally, the quantitative results for ANXA1 expression based on IHC staining and PRM-MS quantification were consistent with the proteomic results, showing that ANXA1 can be used to distinguish FvPTC from FA and FTC. The differentially regulated proteins found in this study can differentiate FA from FvPTC. In addition, ANXA1 is a promising biomarker for differentiating FvPTC from the other thyroid tumors.

摘要

滤泡性甲状腺肿瘤(如滤泡状甲状腺腺瘤 [FA]、滤泡状甲状腺癌 [FTC] 和滤泡型甲状腺乳头状癌 [FvPTC])的诊断仍然具有挑战性。本研究旨在通过蛋白质组学分析探索这三种甲状腺肿瘤之间的分子差异。采用压力循环技术(PCT)-无数据依赖采集(DIA)质谱工作流程,对 52 个福尔马林固定石蜡包埋(FFPE)标本中的蛋白质变化进行研究:18 个 FA、15 个 FTC 和 19 个 FvPTC 标本。对 101 个 FA、67 个 FTC 和 65 个 FvPTC 标本进行免疫组织化学(IHC)分析,并对 20 个 FA、20 个 FTC 和 20 个 FvPTC 标本进行平行反应监测(PRM)分析,以验证蛋白质生物标志物。从 52 个标本中定量了 4107 种蛋白质。FTC 与 FA 之间的成对比较鉴定出 287 个差异调节蛋白,FvPTC 与 FA 之间的比较鉴定出 303 个差异调节蛋白,这两个比较中有 88 个蛋白共同失调。然而,仅在 FTC 和 FvPTC 之间检测到 23 个有区别的蛋白质。此外,基于 IHC 染色和 PRM-MS 定量的 ANXA1 表达的定量结果与蛋白质组学结果一致,表明 ANXA1 可用于区分 FvPTC 与 FA 和 FTC。本研究中发现的差异调节蛋白可区分 FA 与 FvPTC。此外,ANXA1 是一种有前途的生物标志物,可用于区分 FvPTC 与其他甲状腺肿瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5c6/9340356/e4e73ae651e2/fendo-13-854611-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验